MinichMacGregor Wealth Management’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$32.1M Buy
+319,306
New +$32.7M 5.18% 1
2017
Q3
– Sell
-1,191
Closed -$61K – 495
2017
Q2
$61K Sell
1,191
-660
-36% -$33.4K 0.05% 90
2017
Q1
$93K Hold
1,851
– – 0.08% 67
2016
Q4
$87K Hold
1,851
– – 0.08% 71
2016
Q3
$92K Sell
1,851
-2,523
-58% -$128K 0.09% 71
2016
Q2
$210K Buy
4,374
+6
+0.1% +$285 0.2% 35
2016
Q1
$199K Sell
4,368
-66,489
-94% -$3.11M 0.19% 38
2015
Q4
$4.18M Buy
+70,857
New +$3.73M 3.9% 8

Other funds holding IHE

MinichMacGregor Wealth Management's IHE Position: Q3 2026 in Review

MinichMacGregor Wealth Management opened a new position in iShares US Pharmaceuticals ETF (IHE) in Q3 2026: 319,306 shares worth $32.1M. The stake represents 5.18% of the portfolio and ranks #1 among its holdings. This is a return to the name: MinichMacGregor Wealth Management previously reported a position in IHE as recently as Q2 2017.

MinichMacGregor Wealth Management first reported a position in IHE in Q4 2015 and has held it in 8 quarters since. 82 funds tracked by Wall St. Rank hold IHE as of Q3 2026.

  • MinichMacGregor Wealth Management held 319,306 shares of iShares US Pharmaceuticals ETF worth $32.1M as of Q3 2026.
  • iShares US Pharmaceuticals ETF was a new MinichMacGregor Wealth Management position in Q3 2026.
  • iShares US Pharmaceuticals ETF made up 5.18% of MinichMacGregor Wealth Management's portfolio in Q3 2026, its #1 holding.
  • MinichMacGregor Wealth Management first reported a position in iShares US Pharmaceuticals ETF in Q4 2015 and has held it in 8 quarters since.
  • 82 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q3 2026.

Based on MinichMacGregor Wealth Management's 13F filing for Q3 2026, filed 14 Oct 2026.